Five years of successful inducible transgene expression following locoregional adeno-associated virus delivery in nonhuman primates with no detectable immunity
M Guilbaud, M Devaux, C Couzinie, J Le Duff… - Human Gene …, 2019 - liebertpub.com
… long-term inducible expression up to at least 5 years post gene transfer, with no any detectable
host immune response against the transactivator … recombinant adeno-associated virus …
host immune response against the transactivator … recombinant adeno-associated virus …
Tet-on systems for doxycycline-inducible gene expression
AT Das, L Tenenbaum, B Berkhout - Current gene therapy, 2016 - ingentaconnect.com
… A next step in adenoassociated virus-mediated gene therapy for … tetracycline-dependent
transactivator correlates with long-term doxycycline-regulated transgene expression …
transactivator correlates with long-term doxycycline-regulated transgene expression …
A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses
A Chtarto, M Humbert-Claude, O Bockstael… - … therapy Methods & …, 2016 - cell.com
… -sensitive doxycycline-inducible adeno-associated virus (AAV) … regulatable system is the
tetracycline-dependent (tet) system. … Since long-term exposure to antibiotics is undesirable, …
tetracycline-dependent (tet) system. … Since long-term exposure to antibiotics is undesirable, …
Adeno-associated virus vectors and neurotoxicity—lessons from preclinical and human studies
… Recombinant AAV vectors have characteristics that make … These observations suggest that
additional long-term dose … such as the tetracycline-controlled transactivator (tTa) and reverse-…
additional long-term dose … such as the tetracycline-controlled transactivator (tTa) and reverse-…
Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury
… switch, utilizing a chimeric transactivator designed to evade T cell … long term administration
would have any additional advantage over acute transient delivery. Doxycycline-regulated Tet…
would have any additional advantage over acute transient delivery. Doxycycline-regulated Tet…
A drug-tunable gene therapy for broad-spectrum protection against retinal degeneration
… of diseases characterized by the irreversible loss of light-sensitive … , we generated an
adeno-associated virus vector named … that long-term treatment of RPF2 did not alter retinal …
adeno-associated virus vector named … that long-term treatment of RPF2 did not alter retinal …
Peripherally delivered Adeno-associated viral vectors for spinal cord injury repair
JD Sydney-Smith, AB Spejo, PM Warren… - Experimental …, 2022 - Elsevier
… can lead to long-term expression in nonhuman primates but in … Many transactivators are
not derived from mammals and … be rejected by the immune system in humans in the long term; …
not derived from mammals and … be rejected by the immune system in humans in the long term; …
A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivo
… of adeno-associated virus (AAV)-delivered transgenes, … transactivator protein for the Tet-On
transcriptional activation … of plasma Epo after the administration of recombinant protein 32,36 …
transcriptional activation … of plasma Epo after the administration of recombinant protein 32,36 …
Timed GDNF gene therapy using an immune-evasive gene switch promotes long distance axon regeneration
R Eggers, F De Winter, SA Hoyng, RC Hoeben… - Brain, 2019 - academic.oup.com
… Here we used an immune-evasive transactivator generated … short- and sustained long-term
GDNF expression in vivo in … intraspinal adeno-associated viral vector-mediated expression of …
GDNF expression in vivo in … intraspinal adeno-associated viral vector-mediated expression of …
[PDF][PDF] 5 years of successful inducible transgene expression following locoregional AAV delivery in nonhuman primates with no detectable immunity
M Guilbaud, M Devaux, C Couzinié, J Le Duff… - Human Gene …, 2019 - hal.science
… recombinant Adeno-Associated Viruses (… long term inducible expression up to at least 5
years post-gene transfer with no any detectable host immune response against the transactivator …
years post-gene transfer with no any detectable host immune response against the transactivator …